Sep 3, 2025 07:02AM
Sep 3, 2025 07:00AM
Aug 7, 2025 07:02AM
Aug 7, 2025 07:00AM
Apr 30, 2025 07:02AM
Apr 30, 2025 07:00AM
Mar 19, 2025 07:02AM XORTX Therapeutics Inc (XRTX) Announces Update for Discussion with the FDA
Mar 19, 2025 07:00AM
Feb 24, 2025 07:03AM
Feb 24, 2025 07:00AM
Jan 29, 2025 07:00AM
Jan 6, 2025 07:03AM
Jan 6, 2025 07:00AM
Mar 27, 2024 05:51AM XORTX Therapeutics Inc (XRTX) Appoints Ronald Perrone to its Board
Mar 27, 2024 05:00AM
Mar 19, 2024 05:00AM
Aug 29, 2023 07:00AM
Aug 29, 2023 07:00AM
Jun 29, 2023 08:00AM
May 4, 2023 07:11AM
May 4, 2023 07:00AM FDA Confirms Eligibility of XORLO™ for Accelerated Approval
Apr 21, 2023 07:00AM
Apr 21, 2023 07:00AM
Mar 14, 2023 07:05AM
Mar 14, 2023 07:00AM
Feb 22, 2023 06:11PM
Feb 22, 2023 04:32PM
Feb 7, 2023 07:00AM XORTX Provides Update on 2022 Achievements and 2023 Planned Milestones
Feb 1, 2023 07:03AM
Feb 1, 2023 07:00AM
Dec 19, 2022 07:00AM
Dec 8, 2022 07:00AM
Nov 28, 2022 07:00AM
Oct 26, 2022 07:06AM
Oct 26, 2022 07:00AM XORTX Receives Further No Objection Letter from Health Canada
Sep 19, 2022 07:00AM
Aug 4, 2022 07:01AM
Aug 4, 2022 07:00AM
Jul 19, 2022 07:01AM
Jul 19, 2022 07:00AM
Jul 7, 2022 07:03AM
Jul 7, 2022 07:00AM XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)
Jun 6, 2022 07:00AM
May 5, 2022 07:07AM
May 5, 2022 07:00AM
Apr 20, 2022 07:09AM
Apr 20, 2022 07:00AM
Apr 12, 2022 07:05AM
Apr 12, 2022 07:00AM XORTX Receives No Objection Letter from Health Canada
Mar 31, 2022 07:00AM

322,248 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All